Drug–drug plasma protein binding interactions of ivacaftor

By  

JOURNAL OF MOLECULAR RECOGNITION (ELECTRONIC), Vol. 28, Iss. 6, 2015-06 ,pp. : 339-348

John Wiley & Sons Inc

Access to resources Recommend Favorite

Plasma Protein Binding in Drug Discovery and Development

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 13, Iss. 2, 2010-02 ,pp. : 170-187

Bentham Science Publishers

Access to resources Recommend Favorite

Prediction of Drug-Plasma Protein Binding Using Artificial Intelligence Based Algorithms

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 21, Iss. 1, 2018-03 ,pp. : 57-64

Bentham Science Publishers

Access to resources Recommend Favorite

Development and validation of a high‐performance liquid chromatography method for the quantification of talazoparib in rat plasma: Application to plasma protein binding studies

By  

BIOMEDICAL CHROMATOGRAPHY (ELECTRONIC), Vol. 32, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug–Drug Interactions Related to Altered Absorption and Plasma Protein Binding: Theoretical and Regulatory Considerations, and an Industry Perspective

By  

JOURNAL OF PHARMACEUTICAL SCIENCES (ELECTRONIC), Vol. 104, Iss. 3, 2015-03 ,pp. : 916-929

John Wiley & Sons Inc

Access to resources Recommend Favorite